Quantinuum (NASDAQ:QNT) Earns Overweight Rating from Cantor Fitzgerald

Quantinuum (NASDAQ:QNT)‘s stock had its “overweight” rating reiterated by equities research analysts at Cantor Fitzgerald in a note issued to investors on Wednesday,Benzinga reports. They currently have a $90.00 price target on the stock. Cantor Fitzgerald’s target price would suggest a potential upside of 60.54% from the stock’s previous close.

QNT has been the subject of several other reports. Needham & Company LLC reaffirmed a “buy” rating and issued a $100.00 target price on shares of Quantinuum in a research report on Wednesday. Sanford C. Bernstein started coverage on Quantinuum in a research report on Monday, June 29th. They set an “outperform” rating and a $94.00 price objective on the stock. TD Cowen assumed coverage on Quantinuum in a research note on Monday, June 29th. They set a “buy” rating for the company. Craig Hallum started coverage on shares of Quantinuum in a research note on Monday, June 29th. They set a “buy” rating and a $100.00 target price on the stock. Finally, JPMorgan Chase & Co. started coverage on shares of Quantinuum in a report on Monday, June 29th. They set an “overweight” rating and a $97.00 price target for the company. Twelve research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $98.33.

Quantinuum Stock Performance

QNT opened at $56.06 on Wednesday. Quantinuum has a one year low of $47.06 and a one year high of $86.79. The firm has a 50 day simple moving average of $62.71.

Quantinuum (NASDAQ:QNT) last posted its earnings results on Tuesday, August 11th. The company reported ($0.28) EPS for the quarter, missing analysts’ consensus estimates of ($0.26) by ($0.02). The business had revenue of $8.00 million for the quarter. As a group, analysts anticipate that Quantinuum will post -1.61 EPS for the current year.

Insider Transactions at Quantinuum

In other news, Director Kenneth D. Denman purchased 14,000 shares of the company’s stock in a transaction that occurred on Friday, June 5th. The shares were purchased at an average price of $60.00 per share, for a total transaction of $840,000.00. Following the purchase, the director directly owned 19,833 shares of the company’s stock, valued at $1,189,980. This represents a 240.01% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Kevin Scott Dehoff bought 15,000 shares of the stock in a transaction dated Friday, June 5th. The shares were acquired at an average price of $60.00 per share, for a total transaction of $900,000.00. Following the completion of the transaction, the insider owned 126,460 shares of the company’s stock, valued at approximately $7,587,600. The trade was a 13.46% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last quarter, insiders acquired 411,032 shares of company stock worth $24,661,920.

Institutional Investors Weigh In On Quantinuum

A hedge fund recently bought a new stake in Quantinuum stock. Lisanti Capital Growth LLC purchased a new position in shares of Quantinuum Inc. (NASDAQ:QNT) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 5,005 shares of the company’s stock, valued at approximately $409,000.

More Quantinuum News

Here are the key news stories impacting Quantinuum this week:

• Positive Sentiment: Quantinuum reported second-quarter revenue of $8 million, a 279% year-over-year increase, and raised its fiscal 2026 revenue outlook to $28 million-$32 million versus the $26.6 million analyst consensus. Quantinuum Reports Second Quarter 2026 Results
• Positive Sentiment: Quantinuum announced a multiyear partnership with Oracle (NYSE: ORCL) to deploy its 98-qubit Helios system in a U.S.-based Oracle Cloud Infrastructure AI data center. Customers will be able to access hybrid quantum-AI and high-performance computing capabilities through Oracle Cloud without owning specialized quantum hardware, potentially accelerating commercial adoption. Oracle, Quantinuum partner to bring quantum computing to cloud
• Positive Sentiment: The company said Helios demonstrated near five-nines logical fidelity, reinforcing Quantinuum’s positioning in fault-tolerant quantum computing. The Oracle deployment could provide an important bridge from technical milestones to applications such as drug discovery, materials science, financial modeling and optimization. Quantinuum Puts a 98-Qubit Helios Machine Inside Oracle’s AI Data Centers
• Negative Sentiment: Quantinuum reported an adjusted loss of $0.28 per share, slightly worse than the $0.26 consensus estimate. The earnings shortfall and the company’s still-small revenue base appear to have outweighed the favorable outlook and strategic partnership, helping explain why the stock finished lower. Quantinuum Reports Second Quarter 2026 Results

About Quantinuum

Quantinuum is a quantum computing company focused on developing hardware and software for commercial and scientific applications. The company provides access to its quantum systems, along with software tools and services designed to help customers explore use cases in areas such as optimization, materials science, chemistry, cybersecurity, and machine learning.

The company was formed through the combination of Honeywell Quantum Solutions and Cambridge Quantum in 2021. Quantinuum operates internationally and serves a range of customers across enterprise, government, and research markets.